相关实验视频

Updated: Jan 13, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

通过综合虚拟查方法识别白血病的潜在天然BCL-2抑制剂

Uddalak Das^1,2, Arnab Mukherjee³, K S Mukunthan⁴

¹Department of Plant Biotechnology, University of Agricultural Sciences, Bengaluru, Karnataka, 560065, India.

BMC pharmacology & toxicology

|October 29, 2025

概括

研究人员确定了两个天然化合物,CNP0237679和CNP0420384,作为治疗白血病的潜在BCL-2抑制剂. 这些化合物具有低毒性和高生物可用性,为药物开发提供了新的途径.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
计算化学计算化学

背景情况:

白血病涉及BCL-2蛋白的过度表达,促进癌细胞的生存和对亡的抵抗力.
目前的BCL-2抑制剂如Venetoclax具有包括副作用和生物可用性差等局限性.

研究的目的:

通过计算查识别新型,自然衍生的BCL-2抑制剂.
评估已识别的天然化合物的潜在治疗疗效和安全性.

主要方法:

使用基于连接体和结构的虚拟选对407,270种自然化合物的选.
评估结合亲和力,电子性质和水性环境中的稳定性.
预测毒性和药理动力学概况的评估.

主要成果:

两种化合物,CNP0237679和CNP0420384,被确定为有前途的BCL-2抑制剂.
这些化合物表现出强烈的结合亲和力和有利的稳定性.
有前途的毒性和药物动力学特征表明潜在的低毒性和高生物可用性.

结论:

CNP0237679和CNP0420384是开发选择性BCL-2抑制剂的潜在候选者.
这些天然化合物代表了朝着新的白血病治疗方法迈出的有希望的一步.
需要进一步的体外和体内研究来证实治疗疗效和安全性.

关键词:

停靠对接停靠对接药物发现药物发现在白血病中,白血病.分子动力学模拟模型药理动力学药理动力学药科类动物 (Pharmacophore) 是一种药科类动物.

更多相关视频

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...